Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
TIGIT
Biotech
Roche previews Alzheimer's drug that 'drops plaque like a stone'
Think Roche is out of the Alzheimer’s disease business? Think again.
Annalee Armstrong
Feb 1, 2024 11:30am
Gilead stops phase 3 TIGIT trial, doubles down on other studies
Jan 30, 2024 8:09am
Roche racks up phase 3 TIGIT win, but trial design leaves doubts
Jan 17, 2024 5:34am
Coherus axes TIGIT program 2 years after making $35M bet
Jan 10, 2024 7:50am
Merck digs into TIGIT fail with phase 2 lung cancer data drop
Dec 7, 2023 9:37am
Gilead-Arcus' TIGIT gets high response in gastric cancer
Nov 7, 2023 9:40am